Treatment Of Adult Growth Hormone Deficiency After Traumatic Brain Injury.

Growth Hormone Replacement Therapy in Veterans With Mild Traumatic Brain Injury (mTBI) and Adult Growth Hormone Deficiency (AGHD)

NCT04867317 ·Status: RECRUITING ·Phase: PHASE3

Effects of Growth Hormone on Cognition and Cerebral Metabolism in Adults With Growth Hormone Deficiency

NCT01007071 ·Status: COMPLETED ·Phase: PHASE3

Growth Hormone Replacement Therapy for Retried Professional Football Players

NCT04121780 ·Status: RECRUITING ·Phase: PHASE2

Metabolic and QOL Effects of GH Treatment in Patients With TBI and AGHD

NCT02988687 ·Status: COMPLETED

Effect of Somatropin on Left Ventricular Mass in Growth Hormone Deficient Adult Patients

NCT01562834 ·Status: COMPLETED ·Phase: PHASE4

Long Term Effect of Somatropin in Subjects With Intrauterine Growth Retardation

NCT01734447 ·Status: COMPLETED ·Phase: PHASE4

Growth Hormone and Insulin Growth Factor 1 Deficiencies in Children/Adolescents Following Traumatic Brain Injury: The Impact on Growth and Neuropsychological Development

NCT00929045 ·Status: COMPLETED ·Phase: EARLY_PHASE1

Drug Use Investigation of Somatropin for GHD-ADULTS.

NCT00601419 ·Status: COMPLETED

Brain and Gut Plasticity in Mild TBI or Post-acute COVID Syndrome Following Growth Hormone Therapy

NCT03554265 ·Status: COMPLETED ·Phase: PHASE3

Growth Hormone Administration and Its Effects on Cardiovascular Risk Factors in Growth Hormone Deficient Women

NCT00136032 ·Status: COMPLETED ·Phase: NA

Treatment of Adults With Growth Hormone Deficiency

NCT00294619 ·Status: COMPLETED ·Phase: PHASE3

Growth Response in Short Children Suffering From a Disease With Growth Retardation and Treated With Somatropin

NCT00488124 ·Status: COMPLETED ·Phase: PHASE2

Treatment Of Short Stature With Genotropin In Children Born Small For Gestational Age Until Final Height

NCT00174421 ·Status: COMPLETED ·Phase: PHASE3

Anterior Pituitary Hormone Replacement in Traumatic Brain Injury

NCT00957671 ·Status: COMPLETED ·Phase: PHASE4

Efficacy of Somatropin in Adult Patients With Isolated Growth Hormone Deficiency

NCT00630487 ·Status: TERMINATED ·Phase: PHASE3

Evaluation of Efficacy and Safety of Recombinant Somatroipn in Patients With Growth Hormone Deficiency

NCT02693522 ·Status: COMPLETED ·Phase: PHASE3

Individualized, Target-Driven Treatment Of Children With Idiopathic Short Stature

NCT00396097 ·Status: COMPLETED ·Phase: PHASE3

Short Stature Related Distress

NCT01246219 ·Status: COMPLETED ·Phase: PHASE4

Safety and Efficacy Phase 3 Study of Long-acting hGH (MOD-4023) in Growth Hormone Deficient Children

NCT02968004 ·Status: COMPLETED ·Phase: PHASE3

Treatment With Recombinant Human Growth Hormone Genotonorm (Registered) In Children With Short Stature Secondary

NCT00174278 ·Status: COMPLETED ·Phase: PHASE3

Treatment With Recombinant Human Growth Hormone (GH) in Children With Short Stature Secondary to a Long Term Corticoid Therapy

NCT00174187 ·Status: TERMINATED ·Phase: PHASE3

Treatment Of Children With Short Stature At An Age Of 3-7 Years Who Were Born Small For Gestational Age

NCT00174408 ·Status: COMPLETED ·Phase: PHASE3

Extension Study of Pegylated Somatropin to Treat Growth Retardation Caused by Endogenous Growth Hormone Deficiency in Children

NCT03290235 ·Status: UNKNOWN ·Phase: PHASE4

Bioequivalence of Two Somatropin Products (Norditropin® Versus Genotropin®) in Healthy Adult Volunteers

NCT01401244 ·Status: COMPLETED ·Phase: PHASE1

Phase IV Clinical Study of Pegylated Somatropin (PEG Somatropin) to Treat Growth Hormone Deficiency Children (Clinical Trial I)

NCT02380235 ·Status: UNKNOWN ·Phase: PHASE4